Brief Description
In this study, researchers will learn more about the use of felzartamab in participants with immunoglobulin A nephropathy (IgAN). This study will focus on participants who have protein in their urine (proteinuria) as a result of damaged kidneys.
Estimated Enrollment
454
Estimated End Date
June 5th, 2029
Trial is for people with
Immunoglobulin A Nephropathy (IgAN)
Study Goal
The main goal of the study is to learn about the effect felzartamab has on proteinuria. The main question that researchers want to ...
What is involved for the patient?
Participants will be screened to check if they can join the study. Participants will be randomized to receive either felzartamab or a ...
About the drug or intervention
Drug: Felzartamab Drug: Placebo